These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31034104)

  • 1. Dermoscopic similarity is an independent predictor of BRAF mutational concordance in multiple melanomas.
    Moscarella E; Pellegrini C; Pampena R; Argenziano G; Manfredini M; Martorelli C; Ciarrocchi A; Dika E; Peris K; Antonini A; Cipolloni G; Alfano R; Longo C; Fargnoli MC
    Exp Dermatol; 2019 Jul; 28(7):829-835. PubMed ID: 31034104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between dermoscopic and reflectance confocal microscopy features of cutaneous melanoma with BRAF mutational status.
    Bombonato C; Ribero S; Pozzobon FC; Puig-Butille JA; Badenas C; Carrera C; Malvehy J; Moscarella E; Lallas A; Piana S; Puig S; Argenziano G; Longo C
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):643-649. PubMed ID: 27790766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil.
    Armengot-Carbó M; Nagore E; García-Casado Z; Botella-Estrada R
    J Am Acad Dermatol; 2018 May; 78(5):920-926.e4. PubMed ID: 29307636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermoscopic criteria associated with BRAF and NRAS mutation status in primary cutaneous melanoma.
    Pozzobon FC; Puig-Butillé JA; González-Alvarez T; Carrera C; Aguilera P; Alos L; Badenas C; Grichnik JM; Malvehy J; Puig S
    Br J Dermatol; 2014 Oct; 171(4):754-9. PubMed ID: 24749938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations.
    Colombino M; Paliogiannis P; Pagliarello C; Cossu A; Lissia A; Satta R; Mazzoni L; Magi S; Sini MC; Manca A; Casula M; Doneddu V; Palmieri G; Stanganelli I
    Eur J Dermatol; 2018 Apr; 28(2):149-156. PubMed ID: 29180316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype.
    Fargnoli MC; Sera F; Suppa M; Piccolo D; Landi MT; Chiarugi A; Pellegrini C; Seidenari S; Peris K
    J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1768-75. PubMed ID: 24588892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis.
    Pellegrini C; Di Nardo L; Cipolloni G; Martorelli C; De Padova M; Antonini A; Maturo MG; Del Regno L; Strafella S; Micantonio T; Leocata P; Peris K; Fargnoli MC
    J Mol Diagn; 2018 Jan; 20(1):110-122. PubMed ID: 29061376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance of somatic mutational profile in multiple primary melanomas.
    Adler NR; McLean CA; Wolfe R; Kelly JW; McArthur GA; Haydon A; Tra T; Cummings N; Mar VJ
    Pigment Cell Melanoma Res; 2018 Sep; 31(5):592-603. PubMed ID: 29603877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple primary melanomas: do they look the same?
    Moscarella E; Rabinovitz H; Puig S; Zalaudek I; Oliviero MC; Brown L; Alarcon I; Malvehy J; Longo C; Formisano D; Carrera C; Badenas C; Piana S; Albertini G; Pellacani G; Argenziano G
    Br J Dermatol; 2013 Jun; 168(6):1267-72. PubMed ID: 23374221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele frequencies of BRAFV600 mutations in primary melanomas and matched metastases and their relevance for BRAF inhibitor therapy in metastatic melanoma.
    Satzger I; Marks L; Kerick M; Klages S; Berking C; Herbst R; Völker B; Schacht V; Timmermann B; Gutzmer R
    Oncotarget; 2015 Nov; 6(35):37895-905. PubMed ID: 26498143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermoscopic Clues for Diagnosing Melanomas That Resemble Seborrheic Keratosis.
    Carrera C; Segura S; Aguilera P; Scalvenzi M; Longo C; Barreiro A; Broganelli P; Cavicchini S; Llambrich A; Zaballos P; Thomas L; Malvehy J; Puig S; Zalaudek I
    JAMA Dermatol; 2017 Jun; 153(6):544-551. PubMed ID: 28355453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF V600 Mutational Status in Melanoma Correlates with Cytologic Features in Fine-Needle Aspirate Specimens.
    Lee PJ; Dennis K; Madan R; Fan F
    Acta Cytol; 2019; 63(1):10-16. PubMed ID: 30396186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF-V600 Mutation Heterogeneity in Primary and Metastatic Melanoma: A Study With Pyrosequencing and Immunohistochemistry.
    Yaman B; Kandiloğlu G; Akalin T
    Am J Dermatopathol; 2016 Feb; 38(2):113-20. PubMed ID: 26630683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reflectance confocal microscopy features of BRAF V600E mutated thin melanomas detected by immunohistochemistry.
    Urvanegia AC; Tavoloni Braga JC; Shitara D; Fregnani JH; Neves JI; Pinto CA; Marghoob AA; Duprat JP; Rezze GG
    PLoS One; 2017; 12(6):e0179745. PubMed ID: 28662062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF mutation status in primary and metastatic melanomas in two regions with differing potential ultraviolet radiation exposure.
    Massad C; Loya A; Taraif S; Saroufim M; Kibbi AG; Habib R; Novy M; Rauscher B; Oberkanins C; Khalifeh I
    Clin Exp Dermatol; 2014 Dec; 39(8):932-43. PubMed ID: 25262755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive clinical and dermoscopic features of BRAF V600K mutated melanomas.
    Ponti G; Manfredini M; Tomasi A; Pellacani G
    Br J Dermatol; 2015; 172(5):1438-40. PubMed ID: 25323827
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinicopathological features and clinical outcomes associated with TP53 and BRAF
    Kim DW; Haydu LE; Joon AY; Bassett RL; Siroy AE; Tetzlaff MT; Routbort MJ; Amaria RN; Wargo JA; McQuade JL; Kemnade J; Hwu P; Woodman SE; Roszik J; Kim KB; Gershenwald JE; Lazar AJ; Davies MA
    Cancer; 2017 Apr; 123(8):1372-1381. PubMed ID: 27911979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing BRAF mutation status in matched primary and metastatic cutaneous melanomas: implications on optimized targeted therapy.
    Saroufim M; Habib RH; Gerges R; Saab J; Loya A; Amr SS; Sheikh S; Satti M; Oberkanins C; Khalifeh I
    Exp Mol Pathol; 2014 Dec; 97(3):315-20. PubMed ID: 25236573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Histopathologic Characteristics of Melanocytic Lesions on the Volar Skin Without Typical Dermoscopic Patterns.
    Mikoshiba Y; Minagawa A; Koga H; Yokokawa Y; Uhara H; Okuyama R
    JAMA Dermatol; 2019 May; 155(5):578-584. PubMed ID: 30865233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of Dermoscopic Criteria for the Diagnosis of Melanoma In Situ.
    Lallas A; Longo C; Manfredini M; Benati E; Babino G; Chinazzo C; Apalla Z; Papageorgiou C; Moscarella E; Kyrgidis A; Argenziano G
    JAMA Dermatol; 2018 Apr; 154(4):414-419. PubMed ID: 29466542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.